You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 14, April 8, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Capitol Health Call
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Law and Medicine
 •Medical Ethics
 •Violence and Human Rights
 •Human Rights
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Dietary Supplements

Mike Mitka

JAMA. 2009;301(14):1427.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The US Food and Drug Administration (FDA) needs more oversight authority to police dietary supplements and foods that contain supplements, according to a Government Accountability Office (GAO) report.

The March 5 report called for additional FDA regulatory authority over dietary supplement manufacturing facilities and expanded reporting of adverse health effects of these products. The report also recommended that the FDA issue guidance to industry to clarify which supplement ingredients require safety documentation before they can be marketed and also that the agency take steps to improve consumer understanding about these products (http://energycommerce.house.gov/Press_111/20090302/gaoreport.pdf).

The Council for Responsible Nutrition, a supplement trade association, agreed with some of the recommendations in the GAO report but disagreed with the suggestion that all adverse events be reported. The council said only serious adverse events should be reported because the FDA is already overburdened and understaffed.

The Center for Science in the . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.